GreenLight Biosciences Holdings, PBC
CIK 0001822691
Revenue (TTM)
$7.58M
+325.1% YoY
Q1 May 2023
Net Income (TTM)
−$156.76M
−48.7% YoY
Q1 May 2023
EPS Diluted (TTM)
−$1.22
−8.5% YoY
Q1 May 2023
Gross Margin
—
Q1 May 2023
Operating Margin
-2,022.8%
Q1 May 2023
Net Margin
-2,068.9%
Q1 May 2023
Free Cash Flow (TTM)
−$163.28M
Q1 May 2023
Cash
$32.35M
Q1 May 2023
Total Debt
—
Q1 May 2023
Shares Outstanding
151.68M sh
Q1 May 2023